» Articles » PMID: 20041633

Hollow/rattle-type Mesoporous Nanostructures by a Structural Difference-based Selective Etching Strategy

Overview
Journal ACS Nano
Specialty Biotechnology
Date 2010 Jan 1
PMID 20041633
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

A novel "structural difference-based selective etching" strategy has been developed to fabricate hollow/rattle-type mesoporous nanostructures, which was achieved by making use of the structural differences, rather than traditional compositional differences, between the core and the shell of a silica core/mesoporous silica shell structure to create hollow interiors. Highly dispersed hollow mesoporous silica spheres with controllable particle/pore sizes could be synthesized by this method, which show high loading capacity (1222 mg/g) for anticancer drug (doxorubicin). Hemolyticity and cytotoxicity assays of hollow mesoporous silica spheres were conducted, and the synthesized hollow mesoporous silica spheres with large pores show ultrafast immobilization of protein-based biomolecules (hemoglobin). On the basis of this strategy, different kinds of heterogeneous rattle-type nanostructures with inorganic nanocrystals, such as Au, Fe(2)O(3), and Fe(3)O(4) nanoparticles, as the core and mesoporous silica as the shell were also prepared. This strategy could be extended as a general approach to synthesize various hollow/rattle-type nanostructures by creating adequate structural differences between cores and shells in core/shell structures in nanoscale.

Citing Articles

Mesoporous Silica Nanoparticles as an Ideal Platform for Cancer Immunotherapy: Recent Advances and Future Directions.

Godakhindi V, Tarannum M, Dam S, Vivero-Escoto J Adv Healthc Mater. 2024; 13(20):e2400323.

PMID: 38653190 PMC: 11305940. DOI: 10.1002/adhm.202400323.


Magnetic FeO@SiO study on adsorption of methyl orange on nanoparticles.

Li H, Jin H, Li R, Hua J, Zhang Z, Li R Sci Rep. 2024; 14(1):1217.

PMID: 38216581 PMC: 10786890. DOI: 10.1038/s41598-023-50368-x.


How Key Alterations of Mesoporous Silica Nanoparticles Affect Anti-Lung Cancer Therapy? A Comprehensive Review of the Literature.

Budiman A, Rusdin A, Subra L, Aulifa D Int J Nanomedicine. 2023; 18:5473-5493.

PMID: 37791322 PMC: 10542112. DOI: 10.2147/IJN.S426120.


Circularly polarized lanthanide luminescence for advanced security inks.

MacKenzie L, Pal R Nat Rev Chem. 2023; 5(2):109-124.

PMID: 37117607 DOI: 10.1038/s41570-020-00235-4.


Controlled-release of apatinib for targeted inhibition of osteosarcoma by supramolecular nanovalve-modified mesoporous silica.

Wang X, Li G, Li K, Shi Y, Lin W, Pan C Front Bioeng Biotechnol. 2023; 11:1135655.

PMID: 36873361 PMC: 9978000. DOI: 10.3389/fbioe.2023.1135655.